Independent Validation of Forecast Cash Flows of an Indian Dermatology Company to be Acquired by an Asia Pacific Pharma Company

Biotech Consulting Services

Client Challenge

The client was a leading pharmaceutical commercialisation services company in Asia Pacific, with more than 70 brands and over 4,000 employees across 13 countries. They were in discussions with a private Indian dermatology company to acquire the company’s existing brands and were looking for an independent assessment of the sales forecasts for 15 key revenue-driving brands.


Our Approach

To develop sales forecasts for individual brands, UC Strategy triangulated primary and secondary research to:

  • Built an understanding of the key brands considered for acquisition along with the client’s hypothesis and intent
  • Understood market dynamics based on market data and historical performance data
  • Understood the client’s assumptions for the revenue forecast
  • Assessed the factors impacting the revenue model
  • Understood key opinion leaders (KOL) prescription patterns for the therapeutic areas and the active molecules
  • Assessed the competitive landscape for the brands
  • Understood current brand positioning
  • Validated client’s assumptions for the revenue forecast
  • Built framework and develop assumptions for revenue forecast
  • Forecasted revenues for the 15 brands

Our Impact

The client received an independent view of the 10-year sales forecast of the 15 key brands along with key qualitative information based on research feedback.

Leave a Reply

Your email address will not be published. Required fields are marked *